BCL2 and B-cell chronic lymphocytic leukemia: This ‘knock-on’ effect reduces the affinity of BCL2 for venetoclax 180-fold, whereas the affinity for BH3-only proteins is largely unaffected (Fig. 5d).320 However, BCL2 mutations are not identified in all CLL patients who relapse.